Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Levodopa-Induced Dyskinesias in Parkinson's Disease
NCT00291733Phase 2Unknown
- Sponsor
- 1st Hospital of Social Security Services
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levetiracetam in levodopa-induced dyskinesia (LID), sponsored by 1st Hospital of Social Security Services. Primary endpoint: Percent change of 'on with levodopa-induced dyskinesias' time at 24 hours. Status: unknown.
02
Drugs
levetiracetam
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT00291733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291733.